Arch Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 26-06-2024
- Paid Up Capital ₹ 1.16 Cr
as on 26-06-2024
- Company Age 24 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.90 Cr
as on 26-06-2024
- Satisfied Charges ₹ 55.00 Cr
as on 26-06-2024
- Revenue 17180.00%
(FY 2023)
- Profit 25.11%
(FY 2023)
- Ebitda 49.86%
(FY 2023)
- Net Worth -10.38%
(FY 2023)
- Total Assets
About Arch Pharmachem
The Corporate was formerly known as Arch Pharmachem P Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.16 Cr.
The company currently has active open charges totaling ₹3.90 Cr. The company has closed loans amounting to ₹55.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Chetan Shah, Rajendra Kaimal, and Ajit Kamath serve as directors at the Company.
- CIN/LLPIN
U24231MH2000PLC129882
- Company No.
129882
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arch Pharmachem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Kamath  | Director | 29-Jul-2003 | Current |
| Chetan Shah | Director | Current | |
| Rajendra Kaimal | Director | 29-Jul-2003 | Current |
Financial Performance and Corporate Structure Insights of Arch Pharmachem.
Arch Pharmachem Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 17180% increase. The company also saw a substantial improvement in profitability, with a 25.11% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arch Pharmachem?
In 2023, Arch Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arch Life Sciences LimitedActive 21 years 5 daysChetan Shah, Rajendra Kaimal and 1 more are mutual person
Arch Finechemicals LimitedActive 31 years 8 monthsChetan Shah, Rajendra Kaimal and 1 more are mutual person
- Arch Agro Industries Private LimitedActive 13 years 6 months
Rajendra Kaimal and Ajit Kamath are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sahakari Bank Ltd. Creation Date: 21 Jun 2003 | ₹5.00 M | Open |
Sahakari Bank Ltd. Creation Date: 02 Jan 2003 | ₹8.50 M | Open |
Sahakari Bank Ltd. Creation Date: 05 Oct 2002 | ₹2.55 Cr | Open |
How Many Employees Work at Arch Pharmachem?
Unlock and access historical data on people associated with Arch Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arch Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arch Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
